Heartflow, Inc. Common Stock (HTFL)

US — Healthcare Sector

Peers: TARS PRVA LIVN ATEC IRON LEGN SGRY ZLAB PRGO TVTX

Automate Your Wheel Strategy on HTFL

With Tiblio's Option Bot, you can configure your own wheel strategy including HTFL - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

News

HeartFlow: Getting Into The Flow

HTFL
Published: March 19, 2026 by: Seeking Alpha
Sentiment: Positive

HeartFlow delivered 40% sales growth in 2025, with revenue surpassing $176 million and strong Q4 momentum. 2026 guidance targets 25% revenue growth to $218–222 million, with gross margins rising to 80–81% and further mid-term upside to 85%. HearthFlow's AI-driven CAD diagnostic platform is gaining adoption, supported by FDA-cleared next-generation algorithms and a proprietary CT image database.

image for news HeartFlow: Getting Into The Flow

HeartFlow, Inc. (HTFL) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

HTFL
Published: March 03, 2026 by: Seeking Alpha
Sentiment: Neutral

HeartFlow, Inc. (HTFL) Presents at Morgan Stanley Technology, Media & Telecom Conference 2026 Transcript

HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis

HTFL
Published: September 29, 2025 by: Zacks Investment Research
Sentiment: Positive

Heartflow secures FDA clearance and Cigna coverage for its Next Gen Plaque Analysis, boosting accuracy and nationwide access.

image for news HTFL Gains FDA Clearance & Cigna Coverage for Next Gen Plaque Analysis

Medtech firm Heartflow gains 47% in solid Nasdaq debut

HTFL
Published: August 08, 2025 by: Reuters
Sentiment: Positive

Shares of Heartflow rose nearly 47.4% in their Nasdaq debut on Friday, valuing the medical technology company at $2.27 billion.

image for news Medtech firm Heartflow gains 47% in solid Nasdaq debut

About Heartflow, Inc. Common Stock (HTFL)

IPO Date 2025-08-07
Website https://www.heartflow.com
Industry Medical - Healthcare Information Services
CEO John Farquhar
Employees 626

HeartFlow, Inc., a medical technology company, provides non-invasive solutions for diagnosing and managing coronary artery diseases worldwide. Its HeartFlow Platform uses AI and computational fluid dynamics to creates a personalized 3D model of a patient's heart from a single coronary computed tomography angiography, a specialized type of scan that provides detailed images of the heart's arteries. The company's platform provides insights on blood flow, stenosis, and plaque volume and composition by overcoming the limitations of traditional non-invasive imaging tests. The company was founded in 2007 and is headquartered in Mountain View, California.